Nancy Broos

Summary

Affiliation: Netherlands Pharmacovigilance Centre Lareb
Country: The Netherlands

Publications

  1. ncbi Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions
    Eugene van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, s Hertogenbosch, The Netherlands
    Drug Saf 26:293-301. 2003
  2. ncbi Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs
    E P van Puijenbroek
    Netherlands Pharmacovigilance Foundation LAREB, Hertogenbosch
    Eur J Clin Pharmacol 56:733-8. 2000
  3. ncbi Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands
    Eugene P van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, s Hertogenbosch, The Netherlands
    Drug Saf 33:1097-108. 2010
  4. ncbi Spontaneous ADR reports as a trigger for pharmacogenetic research: a prospective observational study in the Netherlands
    Eugene van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, s Hertogenbosch, The Netherlands
    Drug Saf 32:255-64. 2009
  5. ncbi Post Launch Monitoring of food products: what can be learned from pharmacovigilance
    E P van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH s Hertogenbosch, The Netherlands
    Regul Toxicol Pharmacol 47:213-20. 2007
  6. ncbi Slipped capital femoral epiphyses associated with the withdrawal of a gonadotrophin releasing hormone
    Eugene van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5327 MH s Hertogenbosch, Netherlands
    BMJ 328:1353. 2004
  7. ncbi A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
    Eugene P van Puijenbroek
    Netherlands Pharmacovigilance Foundation LAREB, s Hertogenbosch, The Netherlands
    Pharmacoepidemiol Drug Saf 11:3-10. 2002
  8. ncbi Different risks for NSAID-induced anaphylaxis
    Eugene P van Puijenbroek
    Netherlands Pharmacovigilance Foundation LAREB, Goudsbioemvallei 7, s Hertogenbosch, The Netherlands
    Ann Pharmacother 36:24-9. 2002
  9. ncbi Determinants of signal selection in a spontaneous reporting system for adverse drug reactions
    E P van Puijenbroek
    Netherlands Pharmacovigilance Foundation LAREB, s Hertogenbosch, The Netherlands
    Br J Clin Pharmacol 52:579-86. 2001
  10. ncbi Association between terbinafine and arthralgia, fever and urticaria: symptoms or syndrome?
    E P van Puijenbroek
    Netherlands Pharmacovigilance Foundation LAREB, s Hertogenbosch
    Pharmacoepidemiol Drug Saf 10:135-42. 2001

Collaborators

Detail Information

Publications14

  1. ncbi Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions
    Eugene van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, s Hertogenbosch, The Netherlands
    Drug Saf 26:293-301. 2003
    ..Techniques for the detection of drug interactions and syndromes offer a new challenge for pharmacovigilance in the near future...
  2. ncbi Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs
    E P van Puijenbroek
    Netherlands Pharmacovigilance Foundation LAREB, Hertogenbosch
    Eur J Clin Pharmacol 56:733-8. 2000
    ....
  3. ncbi Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands
    Eugene P van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, s Hertogenbosch, The Netherlands
    Drug Saf 33:1097-108. 2010
    ..The accelerated registration procedure of the vaccines used in this campaign and the use of these vaccines on a large scale indicated a need for real-time safety monitoring...
  4. ncbi Spontaneous ADR reports as a trigger for pharmacogenetic research: a prospective observational study in the Netherlands
    Eugene van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, s Hertogenbosch, The Netherlands
    Drug Saf 32:255-64. 2009
    ..An anonymized copy of the test results could be used for the interpretation of possible signals at the pharmacovigilance centre...
  5. ncbi Post Launch Monitoring of food products: what can be learned from pharmacovigilance
    E P van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH s Hertogenbosch, The Netherlands
    Regul Toxicol Pharmacol 47:213-20. 2007
    ..In addition, similarities and differences concerning PMS and PLM are described...
  6. ncbi Slipped capital femoral epiphyses associated with the withdrawal of a gonadotrophin releasing hormone
    Eugene van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5327 MH s Hertogenbosch, Netherlands
    BMJ 328:1353. 2004
  7. ncbi A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
    Eugene P van Puijenbroek
    Netherlands Pharmacovigilance Foundation LAREB, s Hertogenbosch, The Netherlands
    Pharmacoepidemiol Drug Saf 11:3-10. 2002
    ....
  8. ncbi Different risks for NSAID-induced anaphylaxis
    Eugene P van Puijenbroek
    Netherlands Pharmacovigilance Foundation LAREB, Goudsbioemvallei 7, s Hertogenbosch, The Netherlands
    Ann Pharmacother 36:24-9. 2002
    ..The Netherlands Pharmacovigilance Foundation has received a substantial number of anaphylactic reaction reports related to the use of nonsteroidal antiinflammatory drugs (NSAIDs)...
  9. ncbi Determinants of signal selection in a spontaneous reporting system for adverse drug reactions
    E P van Puijenbroek
    Netherlands Pharmacovigilance Foundation LAREB, s Hertogenbosch, The Netherlands
    Br J Clin Pharmacol 52:579-86. 2001
    ..The goal of this study is to gain insight into factors contributing to the selection and dissemination of possible signals originating from the SRS maintained by the Netherlands Pharmacovigilance Foundation...
  10. ncbi Association between terbinafine and arthralgia, fever and urticaria: symptoms or syndrome?
    E P van Puijenbroek
    Netherlands Pharmacovigilance Foundation LAREB, s Hertogenbosch
    Pharmacoepidemiol Drug Saf 10:135-42. 2001
    ..Two patients who reported arthralgia also had a fever. These reports were described in more detail, and analysed statistically in order to determine whether symptoms are interrelated...
  11. ncbi Monitoring adverse events of vaccines against Mexican flu
    E P van Puijenbroek
    Netherlands Pharmacovigilance Centre Lareb, s Hertogenbosch, The Netherlands
    Int J Risk Saf Med 23:81-7. 2011
    ..Differences in reported events between both vaccines may be caused by bias and confounding due to the different populations for which these vaccines have been used...
  12. ncbi Fever following immunization with influenza A (H1N1) vaccine in children: a survey-based study in the Netherlands
    Nancy Broos
    Netherlands Pharmacovigilance Centre Lareb, s Hertogenbosch, The Netherlands
    Drug Saf 33:1109-15. 2010
    ..In the Netherlands, this adverse reaction was a point of concern for the parents or caregivers of these children...
  13. ncbi A data mining approach for signal detection and analysis
    Andrew Bate
    The Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden
    Drug Saf 25:393-7. 2002
    ..Quantitatively unexpectedly strong relationships in the data are highlighted relative to general reporting of suspected adverse effects; these associations are then clinically assessed...
  14. ncbi A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets
    Roland Orre
    Mathematical Statistics, Stockholm University, SE 106 91 Stockholm, and NeuroLogic Sweden AB, Solna, Sweden
    Int J Neural Syst 15:207-22. 2005
    ..With its better scaling properties, the neural network is a promising tool for unsupervised pattern recognition in huge databases of incomplete observations...